• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect Dis . Influenza Attack Rates and Vaccine Effectiveness by Prior-Season Infection and Vaccination: A 17-Season Analysis

tetano

Editor, Senior Moderator
J Infect Dis


. 2026 Jul 11:jiag352.
doi: 10.1093/infdis/jiag352. Online ahead of print.
Influenza Attack Rates and Vaccine Effectiveness by Prior-Season Infection and Vaccination: A 17-Season Analysis

Naoki Kawai[SUP] 1 [/SUP], Takuma Bando[SUP] 1 [/SUP], Takashi Kawashima[SUP] 1 [/SUP], Shinro Matsuura[SUP] 1 [/SUP], Tetsunari Maeda[SUP] 1 [/SUP], Woon Joo Lee[SUP] 1 [/SUP], Shin Nagao[SUP] 1 [/SUP], Hareaki Yamamoto[SUP] 1 [/SUP], Kazuo Mori[SUP] 1 [/SUP], Tokunao Amemiya[SUP] 1 [/SUP], Osame Tanaka[SUP] 1 [/SUP], Ken-Ichi Doniwa[SUP] 1 [/SUP], Ietaka Satoh[SUP] 1 [/SUP], Hideyuki Ikematsu[SUP] 1 [/SUP]


Affiliations
Abstract

Background: Vaccine effectiveness (VE) is commonly interpreted as a measure of protection but may be influenced by differences in baseline risk across populations. The effects of prior-season influenza infection and vaccination on both attack rates (ARs) and VE have not been fully characterized.
Methods: We analyzed 148,108 person-seasons from a 17-season prospective, community-based cohort study in Japan (2002-2003 through 2018-2019). Influenza infection was confirmed using rapid antigen testing. ARs among current-season unvaccinated individuals (a proxy for baseline risk) and vaccinated individuals were compared across groups defined by prior-season infection and vaccination. Adjusted odds ratios (aORs) and relative aORs (rORs) for current-season vaccination were estimated using multivariable logistic regression, with laboratory-confirmed influenza A infection (yes/no) as the outcome.
Results: Among current-season unvaccinated individuals, ARs were higher in those with prior-season vaccination than in those without (14.0% vs 8.6% in children; p<0.001). ARs were similar regardless of prior-season infection but higher with prior-season vaccination. Current-season vaccination reduced odds of influenza A infection (aOR, 0.52; 95% CI, 0.47-0.57). This reduction was more pronounced among individuals with prior-season infection (aOR, 0.35; 95% CI, 0.25-0.49) and less pronounced among those with prior-season vaccination (aOR, 0.59; 95% CI, 0.50-0.70). Protection remained across all groups (aOR <1).
Conclusions: Prior-season infection was associated with enhanced VE of current-season vaccination and similar ARs among vaccinated individuals, whereas prior-season vaccination was associated with attenuated but effective VE. These findings highlight the importance of interpreting AR alongside VE, as ARs reflect differences in baseline risk.

Keywords: attack rate; cohort study; influenza A; prior-season infection; prior-season vaccination; vaccine effectiveness.

 
Back
Top